ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,701Medicare Part D Prescriptions Filled, Including Refills

Rank: 106 out of 939

$668K Total Retail Price of All Prescriptions

Rank: 143 out of 939

409 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 409 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

31% of this provider’s 409 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 11,525 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 699 456 S3 1 1
POTASSIUM CHLORIDE 504 416 2 9
FUROSEMIDE 485 404 3 7
PRAVASTATIN SODIUM 450 330 4 13
SIMVASTATIN 444 352 5 2
LEVOTHYROXINE SODIUM 413 351 6 4
AMLODIPINE BESYLATE 410 357 7 6
LISINOPRIL 406 235 8 3
GABAPENTIN 377 225 9 11
METFORMIN HCL 364 214 10 8
OMEPRAZOLE 332 238 11 5
CITALOPRAM HBR 308 213 12 15
HYDROCHLOROTHIAZIDE 301 217 13 12
WARFARIN SODIUM 286 245 14 17
METOPROLOL TARTRATE 270 238 15 10
TRAMADOL HCL 257 173 16 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 248 157 17 23
NEXIUM 242 196 18 18
GLIPIZIDE 229 177 19 52
ZOLPIDEM TARTRATE 218 162 20 20
MELOXICAM 210 159 21 14
CARVEDILOL 197 177 22 25
AZITHROMYCIN 192 149 23 32
ALLOPURINOL 165 110 24 31
CRESTOR 152 123 25 34
METOPROLOL SUCCINATE 150 128 26 21
PREDNISONE 132 110 27 42
ATENOLOL 128 87 28 19
DONEPEZIL HCL 119 106 29 30
ATORVASTATIN CALCIUM 117 115 30 22
AMITRIPTYLINE HCL 117 65 R 30 38
CYCLOBENZAPRINE HCL 117 42 R 30 36
PROAIR HFA 115 70 33 41
DIGOXIN 108 87 34 45
SERTRALINE HCL 103 77 35 24
FAMOTIDINE 102 66 36 62
TAMSULOSIN HCL 102 80 36 27
FLUTICASONE PROPIONATE 95 59 38 43
CLOPIDOGREL 94 78 39 28
CLONIDINE HCL 92 68 40 39
PAROXETINE HCL 92 46 40 70
CYMBALTA 87 41 42 44
CARISOPRODOL 83 12 R 43 51
AMIODARONE HCL 82 73 44 160
KLOR-CON M10 82 58 44 163
INSULIN SYRINGE 78 41 46 97
ZETIA 77 65 47 103
NAMENDA 77 65 47 49
SPIRONOLACTONE 76 52 49 71
TRIAMTERENE-HCTZ 74 50 50 33
KLOR-CON M20 72 51 51 90
ISOSORBIDE MONONITRATE ER 71 51 52 53
DIOVAN HCT 71 67 52 74
PROMETHAZINE HCL 70 22 R 54 68
RANITIDINE HCL 70 47 54 35
OXYCODONE-ACETAMINOPHEN 69 63 S2 56 138
DILTIAZEM 24HR CD 69 67 56 126
ESCITALOPRAM OXALATE 68 51 58 61
TRAZODONE HCL 67 37 59 26
POLYETHYLENE GLYCOL 3350 66 58 60 57
LANTUS 64 25 61 59
DOXAZOSIN MESYLATE 63 45 62 108
ALENDRONATE SODIUM 61 59 63 40
SUCRALFATE 61 55 63 96
PLAVIX 60 46 65 48
DIOVAN 59 59 66 50
ADVAIR DISKUS 58 45 67 60
LOSARTAN POTASSIUM 57 40 68 29
CELEBREX 57 42 68 106
NAPROXEN 56 29 70 72
VERAPAMIL ER 55 35 71 85
HUMALOG 55 34 71 215
AMLODIPINE BESYLATE-BENAZEPRIL 55 54 71 58
LEVEMIR 54 33 74 168
PHENYTOIN SODIUM EXTENDED 53 16 75 99
TRICOR 53 49 75 143
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 31 77 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.